Researchers identified a small molecule capable of stimulating nerve regeneration and restoring vision following injury to the optic nerve.
Study uncovers new genetic risk factors for age-related macular degeneration, a leading cause of vision loss in adults.
Study demonstrates two different types of deposits in the retina that appear to contribute to age-related macular degeneration.
New AI technology is able to detect changes to the retina and predict the risk of retinal vein occlusion. Researchers say the technology could also be used to detect heart attack and stroke risks.
People with subretinal drusenoid deposits (SDD), a form of age-related macular degeneration, are more likely to have underlying heart damage as a result of heart failure or heart attacks, or other forms of cardiovascular disease associated with increased stroke risk.
Those who suffer from poor sleep quality, including daytime sleepiness, snoring, or getting too much or too little sleep, are at increased risk of developing glaucoma.
Administering a chemical compound called synthetic retinoids to the retina helped restore brain networks associated with vision and prompted the growth of two times more neurons, effectively restoring vision in adult mouse models of the genetic visual disorder LCA.
The loss of blood flow autoregulation caused by diabetes is the result of the disruption of the TRPV2 protein. Even in the absence of diabetes, disrupted blood flow autoregulation causes damage closely resembling that seen in diabetic retinopathy.
Determining the structure of vitronectin, a protein implicated in age-related macular degeneration and some neurodegenerative disorders, and using pressure to alter the protein shape may help in the development of new treatments for AMD.
A new study reports that a new gene therapy shows promise in treating dry age-related macular degeneration. The gene therapy, ophNdi1, directly targets mitochondrial function that is malfunctioning in AMD.
The discovery of new genetic signatures associated with age-related macular degeneration may lead to better diagnosis and treatment of the currently incurable vision disorder.
Researchers say Black patients are at greater risk of advanced vision loss than white patients following a diagnosis of primary open angle glaucoma.